比尔·盖茨宣布投1亿美元攻克阿兹海默症

2017-11-14 陈桦(编译) 腾讯科技

随着人类寿命的延长,阿兹海默症和其他类型老年痴呆症发病率的不断上升正带来越来越大的情感和经济损失。

据外媒报道,微软联合创始人比尔·盖茨(Bill Gates)本周宣布,向风投基金Dementia Discovery Fund(DDF)投资5000万美元。这只基金的目标是将行业和政府联系在一起,推动对老年痴呆症的研究。

盖茨表示,这笔投资并不是盖茨慈善基金会投资的一部分,此外他还将向多家研究阿兹海默症的创业公司再投资5000万美元。他表示,随着人类寿命的延长,阿兹海默症和其他类型老年痴呆症发病率的不断上升正带来越来越大的情感和经济损失。

盖茨指出:“这是个大问题,一个日趋严重的问题。即使是对仍然活着的人来说,悲剧也非常惨痛。”

尽管相关的科学研究已经持续了几十年,但目前还没有任何治疗方式可以减缓阿兹海默症的发病进程。当前的药物最多只能缓解一些症状。

然而盖茨认为,如果在充足资金的支持下去展开研究,那么他对于治疗方式的探索“非常乐观”,即使这可能还要超过10年的时间。“或许需要10年,新理论才能有足够的时间找到较高的成功机会。因此,很难猜测有效的药物何时会被开发出来。我希望未来10年,我们能找到有效的药物,但这可能无法实现。”

根据非营利组织Alzheimer's Disease International的报告,老年痴呆症目前影响了全球范围内的5000万人,到2050年这一数字预计还将上升至1.31亿。

DDF成立于2015年,参与者包括葛兰素史克、强生、礼来、辉瑞和Biogen Idec等多家医药巨头,以及英国政府。该基金已投资了至少9家创业公司,研究如何阻止老年痴呆症发病的生物变化,甚至逆转这一过程。

盖茨表示,另5000万美元将被投入至一些“不太主流”的治疗方法上。不过他表示,尚未确定具体投资哪些公司。

此前,盖茨慈善活动关注的主要问题是贫穷国家的传染病。他表示,之所以关注阿兹海默症部分是由于他的个人原因。此外到目前为止,这仍然是一种非常棘手的疾病。盖茨表示,自己家族中有人患有阿兹海默症。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=286766, encodeId=dfc9286e6630, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sat Feb 10 09:44:15 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724329, encodeId=5bf41e243295e, content=<a href='/topic/show?id=93b663639f4' target=_blank style='color:#2F92EE;'>#比尔·盖茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63639, encryptionId=93b663639f4, topicName=比尔·盖茨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adf833602168, createdName=yangcx0926, createdTime=Thu Sep 20 13:31:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465347, encodeId=c29a146534e34, content=<a href='/topic/show?id=78829e719a0' target=_blank style='color:#2F92EE;'>#阿兹海默症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97719, encryptionId=78829e719a0, topicName=阿兹海默症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e96710983, createdName=jiekemin, createdTime=Thu Nov 16 02:31:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261261, encodeId=7aef261261f9, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Nov 14 15:18:27 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261258, encodeId=6bdf2612584f, content=一亿恐怕不够, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Tue Nov 14 14:27:55 CST 2017, time=2017-11-14, status=1, ipAttribution=)]
    2018-02-10 1e145228m78(暂无匿称)

    学习了.谢谢作者分享!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=286766, encodeId=dfc9286e6630, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sat Feb 10 09:44:15 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724329, encodeId=5bf41e243295e, content=<a href='/topic/show?id=93b663639f4' target=_blank style='color:#2F92EE;'>#比尔·盖茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63639, encryptionId=93b663639f4, topicName=比尔·盖茨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adf833602168, createdName=yangcx0926, createdTime=Thu Sep 20 13:31:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465347, encodeId=c29a146534e34, content=<a href='/topic/show?id=78829e719a0' target=_blank style='color:#2F92EE;'>#阿兹海默症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97719, encryptionId=78829e719a0, topicName=阿兹海默症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e96710983, createdName=jiekemin, createdTime=Thu Nov 16 02:31:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261261, encodeId=7aef261261f9, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Nov 14 15:18:27 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261258, encodeId=6bdf2612584f, content=一亿恐怕不够, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Tue Nov 14 14:27:55 CST 2017, time=2017-11-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=286766, encodeId=dfc9286e6630, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sat Feb 10 09:44:15 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724329, encodeId=5bf41e243295e, content=<a href='/topic/show?id=93b663639f4' target=_blank style='color:#2F92EE;'>#比尔·盖茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63639, encryptionId=93b663639f4, topicName=比尔·盖茨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adf833602168, createdName=yangcx0926, createdTime=Thu Sep 20 13:31:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465347, encodeId=c29a146534e34, content=<a href='/topic/show?id=78829e719a0' target=_blank style='color:#2F92EE;'>#阿兹海默症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97719, encryptionId=78829e719a0, topicName=阿兹海默症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e96710983, createdName=jiekemin, createdTime=Thu Nov 16 02:31:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261261, encodeId=7aef261261f9, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Nov 14 15:18:27 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261258, encodeId=6bdf2612584f, content=一亿恐怕不够, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Tue Nov 14 14:27:55 CST 2017, time=2017-11-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=286766, encodeId=dfc9286e6630, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sat Feb 10 09:44:15 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724329, encodeId=5bf41e243295e, content=<a href='/topic/show?id=93b663639f4' target=_blank style='color:#2F92EE;'>#比尔·盖茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63639, encryptionId=93b663639f4, topicName=比尔·盖茨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adf833602168, createdName=yangcx0926, createdTime=Thu Sep 20 13:31:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465347, encodeId=c29a146534e34, content=<a href='/topic/show?id=78829e719a0' target=_blank style='color:#2F92EE;'>#阿兹海默症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97719, encryptionId=78829e719a0, topicName=阿兹海默症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e96710983, createdName=jiekemin, createdTime=Thu Nov 16 02:31:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261261, encodeId=7aef261261f9, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Nov 14 15:18:27 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261258, encodeId=6bdf2612584f, content=一亿恐怕不够, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Tue Nov 14 14:27:55 CST 2017, time=2017-11-14, status=1, ipAttribution=)]
    2017-11-14 doctorJiangchao

    谢谢分享.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=286766, encodeId=dfc9286e6630, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sat Feb 10 09:44:15 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724329, encodeId=5bf41e243295e, content=<a href='/topic/show?id=93b663639f4' target=_blank style='color:#2F92EE;'>#比尔·盖茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63639, encryptionId=93b663639f4, topicName=比尔·盖茨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adf833602168, createdName=yangcx0926, createdTime=Thu Sep 20 13:31:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465347, encodeId=c29a146534e34, content=<a href='/topic/show?id=78829e719a0' target=_blank style='color:#2F92EE;'>#阿兹海默症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97719, encryptionId=78829e719a0, topicName=阿兹海默症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e96710983, createdName=jiekemin, createdTime=Thu Nov 16 02:31:00 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261261, encodeId=7aef261261f9, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Nov 14 15:18:27 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261258, encodeId=6bdf2612584f, content=一亿恐怕不够, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Tue Nov 14 14:27:55 CST 2017, time=2017-11-14, status=1, ipAttribution=)]
    2017-11-14 坚强007

    一亿恐怕不够

    0

相关资讯

Mol Psy:新技术可检测阿兹海默症患者脑部的tau蛋白的沉积与扩散特征

在最近发表在《Molecular Psychiatry》杂志上的一项研究中,科学家们检测了阿兹海默症患者在发病过程的不同阶段大脑中tau蛋白沉积样的扩散特征。这一结果表明沉积斑块的的大小以及其扩散的速度具有明显的个体差异性,而大脑中tau蛋白的水平与记忆损伤的严重程度之间也有明显的相关性。 在阿兹海默症发病的早期,大脑中已经有了tau

PNAS:治疗阿兹海默症新机制:早老素的磷酸化导致β淀粉样前体蛋白降解

这一发现显示除了传统意义上参与β-淀粉样蛋白的合成,早老素1通过磷酸化自我调控抑制过度产生β-淀粉样蛋白。这一反馈性的抑制作用,可以认为是细胞自我保护的一个步骤。基于此发现,未来可以开发药物旨在提高早老素1蛋白在Ser367磷酸化水平并应用于治疗阿尔茨海默氏病。

Blood:阿兹海默症的早期症状及引起原因

随着人们平均年龄的不断增加,患阿兹海默症的人数也与日俱增,这种疾病逐渐成为了最常见的神经系统疾病之一,近年来, 科学家们已经探索了许多新方法,清除大脑斑块和神经元纤维缠结, 但新药在很大程度上被证明是令人失望的。

新开发的DNA疫苗能够有效预防阿兹海默症的发生

最近一项研究成功地设计出了用于皮下注射的靶向阿兹海默症的DNA疫苗。该疫苗能够引发机体产生针对阿兹海默症毒性蛋白的特异性抗体。 这一由Peter O'Donnell Jr.脑研究所的科学家们做出的研究成果在动物水平证明了含有beta淀粉样蛋白的编码DNA的疫苗能够引发良好的免疫反应,而且该疫苗对于临床使用具有一定的安全性。 该研究的共

SCI REP:阿兹海默症竟是肺癌“克星”,科学家找到治疗肺癌新线索!

阿尔茨海默氏症患者患胶质母细胞瘤的风险增加,而患肺癌的风险却降低。一份来自西班牙国家癌症研究中心(CNIO)研究报告描述了这个疾病的生物过程

记忆认知与阿兹海默症之间的关系

目前世界上有超过20%的成年人面临主观性记忆损伤的困扰,即自我感觉记忆力受到了影响,但实际上并没有记忆缺失的症状。如今,来自宾州州立大学的研究者们发现,对于一些老年人来说主观性记忆损伤会导致阿兹海默症的发生。护理学系的助理教授Nikki Hill希望能够搞清楚自我感觉记忆力缺陷、抑郁、焦虑以及活跃程度下降等症状是否会随着时间推移导致真正